Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain

Abstract excerpt

Prostate cancer (PCa) is the second most common cause of cancer-related mortality in men in the United States. The androgen receptor (AR) and the physiological pathways it regulates are central to the initiation and progression of PCa. As a member of the nuclear steroid receptor family, it is a transcription factor with three distinct functional domains (ligand-binding domain [LBD], DNA-binding domain [DBD], and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Multiple Myeloma Research and Treatments
• Share to Prostate Cancer Treatment and Research
• Share to Protein Degradation and Inhibitors